Cardiovascular diseases (CVDs) have maintained a relentless grip as the primary cause of death among women worldwide since 2002, sounding an urgent call for focused attention and reform in women's healthcare. Disturbingly, women experiencing cardiac arrests are only half as likely to survive as their male counterparts, underscoring the gravity...
Imageens, a French leading startup in medical technology, has been awarded the prestigious EIT Health grant for its cutting-edge solution, Artfun+. This revolutionary technology plays a pivotal role in the CMRAI project in partnership with Sorbonne University and Siemens, aiming to revolutionize precision cardiovascular medicine in aortic aneurysm through advanced...Read More
Artfun+, powered by Imageens, has received Class 2a approval under the EU's new Medical Device Regulation (EU MDR), becoming the world's most clinically validated device measuring MRI imaging biomarkers related to arterial stiffness and cardiovascular diseases. This breakthrough promises to transform cardiovascular risk assessment for clinicians worldwide. Cardiovascular diseases are...Read More
In the objective of advancing athletic performance and health, Imageens, a leading MedTech startup has forged a strategic partnership with CHU Nancy (Centre Hospitalier Universitaire de Nancy). This pioneering collaboration is set to redefine the way arterial stiffness is measured in high-level athletes, contributing to a deeper understanding of cardiovascular...Read More
The webinar conducted by Imageens ( link) focused on the role of imaging biomarkers in primary prevention of cardiovascular diseases (CVD). The webinar featured two leading speakers: Professor Alban Redheuil, head of cardiovascular radiology at La Pitié Salpêtrière, and Dr. Antonio Gallo, a lipidologist in the cardiovascular prevention unit at...
Imageens is proud to announce that it has teamed up with a consortium of medical professionals, researchers, and engineers across Europe to launch a transformative initiative named CMRAI. The project, funded by the European Union under the EIT Health framework, is poised to revolutionize the prognosis and management of aortic...Read More
Artfun+ solution has laid the foundation for an extraordinary breakthrough – a predictive clinical decision tool named CardioInspect. This visionary solution harnesses the power of Artfun+ technology to drive accurate cardiovascular age and risk analysis. Based on the years of research and clinical validation of Artfun+, CardioInspect aims to revolutionize...Read More
In a remarkable stride towards advancing medical diagnostics and treatment, Pitié-Salpêtrière Hospital, a beacon of excellence in the healthcare realm and consistently ranked among the world's top 10 best hospitals, has chosen to harness the power of Artfun+, a cutting-edge technology. Developed by Imageens a French leading startup in medical...Read More
Imageens is thrilled to announce that we had the honor of participating in the prestigious TEDx event, where an enlightening presentation on the topic of "How Cardiovascular Age Measured from Arterial Stiffness Biomarkers is Preventing Cardiovascular Diseases." The event provided a remarkable platform for sharing our innovative insights and solutions....Read More
Inselspital de Bern, a leading medical center renowned for its excellence in patient care and research shows interest to use Imageens solution, Artfun+ and Cardioinspect for transforming cardiovascular health assessment and management. By combining Imageens' technological expertise with Inselspital de Bern's clinical excellence, patients can look forward to a future where early detection and proactive...Read More